Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Colonic Neoplasms 2Anus Neoplasms 2Rectal Neoplasms 1Pathologic Complete Response 1Lymphoma, Mantle-Cell 1HIV Infections 1Digestive System Diseases 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Anal Canal Carcinoma 1Adenomatous Polyposis Coli 1

Interventions

Specimen Handling 3Biopsy 3Endoscopy, Gastrointestinal 2trifluridine tipiracil drug combination 1obeticholic acid 1Thiamine 1Sirolimus 1Sigmoidoscopy 1Oxaliplatin 1Nivolumab 1Leucovorin 1Gastroscopy 1Fluorouracil 1Exercise Therapy 1Endoscopy, Digestive System 1Colonoscopy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Colonoscopy × 90 days × Clear all
NCT05630794 2026-05-13

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

National Cancer Institute (NCI)

Phase 1 Recruiting
36 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡